M. Soengas
Molecular Biology · 2001–2006
A researcher in the Science corpus: 4 papers; trusts 6 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 38 citations into it
- Oncology — 13 citations into it
- Immunology — 6 citations into it
- Cancer Research — 5 citations into it
Whom M. Soengas trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- F. Igney
- Scott W. Lowe
- P. Krammer
- Lewis C. Cantley
- A. Baldwin
- Harald Wajant
- D. Hanahan
- M. Karin
- Marcel Leist
- G. Salvesen
Who trusts M. Soengas overall
Papers from M. Soengas's perspective
Ordered by how strongly the researchers M. Soengas trusts endorse each paper. Same corpus, a different order for every researcher.
- The Hallmarks of Cancer Review
- Inactivation of the apoptosis effector Apaf-1 in malignant melanoma (Nature)
- CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus (Nature)
- Four deaths and a funeral: from caspases to alternative mechanisms (Nature reviews. Molecular cell biology)
- Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene (Nature)
- DNA hypermethylation in tumorigenesis: epigenetics joins genetics. (Trends in Genetics)
- Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. (Cancer Cell)
- Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. (Molecules and Cells)
- DNA methylation: past, present and future directions. (Carcinogenesis)
- The phosphoinositide 3-kinase pathway. (Science)
Their papers
- Inactivation of the apoptosis effector Apaf-1 in malignant melanoma (2001) — 1,008 citations
- BRAFE600-associated senescence-like cell cycle arrest of human naevi (2005) — 2,216 citations
- Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. (2006) — 1,020 citations
- Apoptosis and melanoma chemoresistance (2003) — 828 citations